COMPUGROUP MEDSPADR (Germany) Top Insiders
COPA Stock | EUR 22.00 1.00 4.76% |
Examination of COMPUGROUP MEDSPADR's management performance can provide insight into the company performance.
COMPUGROUP |
Symbol | COPA |
Name | COMPUGROUP MEDSPADR 1 |
Type | Stock |
Country | Germany |
Exchange | F |
Information on COMPUGROUP MEDSPADR 1 Leadership is currently not available.
If you believe this information is not accurate please let us know and we will check it out. Check all delisted instruments across multiple markets.Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
BTC | Bitcoin | |
TRX | TRON | |
BNB | Binance Coin | |
ADA | Cardano | |
XRP | XRP |
Thematic Opportunities
Explore Investment Opportunities
COMPUGROUP MEDSPADR Management Team Effectiveness
The company has return on total asset (ROA) of 0.031 % which means that it generated a profit of $0.031 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1118 %, meaning that it generated $0.1118 on every $100 dollars invested by stockholders. COMPUGROUP MEDSPADR's management efficiency ratios could be used to measure how well COMPUGROUP MEDSPADR manages its routine affairs as well as how well it operates its assets and liabilities.COMPUGROUP MEDSPADR Workforce Comparison
COMPUGROUP MEDSPADR 1 is number one stock in number of employees category among its peers. The total workforce of Health Information Services industry is currently estimated at about 20,389. COMPUGROUP MEDSPADR totals roughly 8,833 in number of employees claiming about 43% of equities under Health Information Services industry.
The company has Profit Margin (PM) of 0.06 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.08 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.08. COMPUGROUP MEDSPADR Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. COMPUGROUP MEDSPADR Price Series Summation is a cross summation of COMPUGROUP MEDSPADR price series and its benchmark/peer.
About COMPUGROUP MEDSPADR Management Performance
The success or failure of an entity such as COMPUGROUP MEDSPADR often depends on how effective the management is. COMPUGROUP MEDSPADR management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of COMPUGROUP management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the COMPUGROUP management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
KGaA develops and sells software and information technology solutions for the healthcare sector worldwide. KGaA was founded in 1987 and is headquartered in Koblenz, Germany. COMPUGROUP MED is traded on Frankfurt Stock Exchange in Germany.
Complementary Tools for COMPUGROUP Stock analysis
When running COMPUGROUP MEDSPADR's price analysis, check to measure COMPUGROUP MEDSPADR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy COMPUGROUP MEDSPADR is operating at the current time. Most of COMPUGROUP MEDSPADR's value examination focuses on studying past and present price action to predict the probability of COMPUGROUP MEDSPADR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move COMPUGROUP MEDSPADR's price. Additionally, you may evaluate how the addition of COMPUGROUP MEDSPADR to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |